Skip to main content
Clinical Trials/NCT04257188
NCT04257188
Completed
Not Applicable

A Prospective, One-center Clinical Trial to Identify the Safety and Feasibility of Sutureless Pars-plana Vitrectomy Performed in Sub-tenon Anesthesia.

RWTH Aachen University1 site in 1 country67 target enrollmentNovember 7, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vitreoretinal Diseases
Sponsor
RWTH Aachen University
Enrollment
67
Locations
1
Primary Endpoint
Discomfort
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of this prospective study is to investigate the feasibility of performing minimally invasive vitrectomy under sub-tenon anesthesia in terms of intraoperative patients' tolerance and the surgeon's confidence. In particular, the tolerance and pain sensation during the operation as well as the possible perception of light and colour sensations are to be recorded with the help of questionnaires. In addition, the surgeon's impressions regarding eye motility, chemosis and general feasibility will be evaluated.

Detailed Description

A prospective, one-center clinical trial to identify the safety and feasibility of sutureless pars-plana vitrectomy performed in sub-tenon anesthesia. Background: In Germany pars-plana vitrectomies are mostly performed in general anesthesia. This requires the immediate availability of a trained anesthesiology team, which is not always granted, especially in urgent eye disease (i.e. endophthalmitis, high risk retinal detachment). Furthermore, some patients are not suitable for general anesthesia due to systemic diseases (i.e. cardio-vascular diseases). There are several procedures of local ocular anesthesia (i.e. peribulbar, retrobulbar, sub-tenon anesthesia). The main advantage of sub-tenon anesthesia is the use of a blunt cannula limiting the risk of potential complications. Purpose: The purpose of this study is to investigate the safety of local sub-tenon anesthesia procedure for sutureless vitrectomy (anesthetic mixture: 2ml xylocaine and 2ml bupivacaine) in a prospective clinical study design. Objectives: Primary outcome: The evaluation of 1. sensation of pain, 2. patients' intraoperative discomfort and 3. visual sensations using the standardized questionnaires (WONG-BAKER Faces Scale, Visual Analog Scale and individual questions). Secondary Outcome: The evaluation of 1. chemosis, 2. eye movement, 3. surgeon's general feeling of comfort during surgery (rating scale).

Registry
clinicaltrials.gov
Start Date
November 7, 2019
End Date
March 31, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Antonis Koutsonas

Dr. med. Antonis Koutsonas

RWTH Aachen University

Eligibility Criteria

Inclusion Criteria

  • Age over 40 years
  • Presence of a clinical condition that requires surgical treatment with vitrectomy and does not necessarily require general anesthesia (retinal detachment, endophthalmitis, vitreous hemorrhage, after silicone oil surgery, vitreomacular traction, epiretinal gliosis, macular holes, subretinal bleeding, lens luxation).
  • The medical indication for vitrectomy is not linked to study participation. Not until the patient has consented to the vitrectomy (standardized information forms) potential study subjects will be approached to participate in the clinical trial.
  • Willingness to participate in the clinical trial
  • Understanding the objectives of the clinical trial and the study process
  • Signed informed consent form

Exclusion Criteria

  • Concomitant diseases of the eye
  • State after filtering glaucoma operations
  • Distinct corneal opacities, which make the examination considerably more difficult
  • Complicated proliferative vitreoretinopathy
  • Lack of understanding of the study, its objectives and study conduct
  • Psychiatric diseases
  • Pregnancy
  • Simultaneous participation in another clinical trial

Outcomes

Primary Outcomes

Discomfort

Time Frame: 1 Day

11-point numeric scale ranges from '0' (means "no discomfort") to '10' (means "worst discomfort imaginable"), Questionnaire

Sensation of pain

Time Frame: 1 Day

1. 11-point numeric scale ranges from '0' (means "no pain") to '10' (means "worst pain imaginable"), Questionnaire 2. Wong-Baker FACES® Scale (6 Faces, range no hurt - hurts worst), Questionnaire

Visual Sensations

Time Frame: 1 Day

4 questions, Likert scale ("yes", "no", "don't know/not sure"), Questionnaire 1. perception of details during surgery (instruments, surgeon's face) 2. perception of colors during surgery 3. perception of lights or shadows 4. no light perception at all during surgery

Secondary Outcomes

  • Chemosis(1 Day)
  • Eye movement(1 Day)
  • Surgeon's general feeling of comfort during the surgery(1 Day)

Study Sites (1)

Loading locations...

Similar Trials